Company profile for CorMedix

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

CorMedix Inc. is a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases. The Company is focused on developing its lead investigational drug product, Neutrolin®, a novel, non-antibiotic antimicrobial solution designed to prevent catheter-related bloodstream infections (“CRBSIs”) in patients with end-stage renal dis...
CorMedix Inc. is a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases. The Company is focused on developing its lead investigational drug product, Neutrolin®, a novel, non-antibiotic antimicrobial solution designed to prevent catheter-related bloodstream infections (“CRBSIs”) in patients with end-stage renal disease receiving hemodialysis through a central venous catheter.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
400 Connell Drive Suite 5000 Berkeley Heights, NJ
Telephone
Telephone
+1 908-517-9500
Linkedin
Linkedin
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

DCAT Week

DCAT Week

Not Confirmed

envelop Contact Supplier

DCAT Week

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.globenewswire.com/news-release/2025/11/12/3186117/0/en/CorMedix-Inc-Reports-Third-Quarter-2025-Financial-Results-and-Updates-FY-2025-Guidance.html

GLOBENEWSWIRE
12 Nov 2025

https://www.globenewswire.com/news-release/2025/10/31/3178302/0/en/CorMedix-Inc-to-Report-Third-Quarter-2025-Financial-Results-and-Provide-a-Corporate-Update-on-November-12-2025.html

GLOBENEWSWIRE
31 Oct 2025

https://www.globenewswire.com/news-release/2025/10/23/3172021/0/en/CorMedix-Inc-Receives-Innovative-Technology-Designation-From-Vizient-for-DefenCath.html

GLOBENEWSWIRE
23 Oct 2025

https://www.globenewswire.com/news-release/2025/10/20/3169259/0/en/CorMedix-Inc-Announces-Preliminary-Third-Quarter-2025-Results-and-Raises-2025-Net-Revenue-Guidance.html

GLOBENEWSWIRE
20 Oct 2025

https://www.globenewswire.com/news-release/2025/09/29/3157711/0/en/CorMedix-Announces-Completion-of-Enrollment-in-Phase-III-ReSPECT-Clinical-Trial-for-REZZAYO.html

GLOBENEWSWIRE
29 Sep 2025

https://www.globenewswire.com/news-release/2025/09/08/3146092/0/en/CorMedix-Announces-Strategic-Minority-Investment-in-Talphera.html

GLOBENEWSWIRE
08 Sep 2025

ABOUT THIS PAGE

Contact CorMedix and get a quotation

CorMedix is a supplier offers 1 products (APIs, Excipients or Intermediates).

Find a price of Taurolidine bulk with DMF offered by CorMedix

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty